glucose, (beta-d)-isomer has been researched along with Cancer of Ovary in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (13.04) | 18.7374 |
| 1990's | 3 (13.04) | 18.2507 |
| 2000's | 2 (8.70) | 29.6817 |
| 2010's | 12 (52.17) | 24.3611 |
| 2020's | 3 (13.04) | 2.80 |
| Authors | Studies |
|---|---|
| Fumarulo, R; Giordano, D; Restaino, A; Riccardi, S | 1 |
| Briantais, MJ; Brivet, M; Galanaud, P; Khellaf, A; Lebrun, L; Pelletier, G | 1 |
| Chen, DW; Huang, JZ; Li, LL; Luo, X; Tan, XY; Wu, ZY | 1 |
| Gu, X; Hill, RA; Hosain, SB; Khiste, SK; Liu, YY; Liu, Z; Nazzal, S; Roy, KR; Uddin, MB | 1 |
| Cui, W; He, Y; Li, X; Wei, L; Zhang, J; Zhang, S | 1 |
| Chen, Z; Jiang, ZK; Li, X; Ping, FF; Wang, X; Zhao, YQ | 1 |
| Chen, XJ; Lu, HS; Lv, RW; Qu, XD; Wang, Y; Zhang, LQ | 1 |
| Jia, L; Jin, H; Lu, Y; Lv, M; Ming, Y; Yu, Y; Zhao, H; Zhao, N; Zheng, Z; Zhou, J | 1 |
| Cholujova, D; Duraj, J; Galova, E; Horvathova, E; Karnisova Potocka, E; Klapakova, M; Mastihuba, V; Mastihubova, M; Sevcovicova, A; Zduriencikova, M | 1 |
| Chen, L; Chen, W; Huang, W; Li, N; Lin, H; Lin, Z; Ming, Y; Xiao, J; Zheng, Y; Zheng, Z | 1 |
| He, SH; Li, BY; Liu, HG; Xue, CL; Yue, QF | 1 |
| Chen, Y; Li, J; Yan, Y; Yang, J; Yang, X | 1 |
| Chen, L; Jia, L; Jin, H; Lu, Y; Ming, Y; Yu, Y; Zhou, J | 1 |
| Delman, DM; Fabian, CJ; Kimler, BF; Petroff, BK; Yeh, H | 1 |
| Liu, S | 1 |
| Choi, JH; Jang, DS; Kim, HM; Ryu, B; Woo, JH | 1 |
| Gao, J; Zeng, L; Zhang, R | 1 |
| Harstrick, A; Hilger, RA; Rustum, YM; Seeber, S; Vanhoefer, U; Voigt, W; Yin, MB | 1 |
| Ames, MM; Aytes, SA; Kuffel, MJ; Lineswala, JP; Zembower, DE; Zhang, H | 1 |
| Crommelin, DJ; Eggenhuisen, MH; Hennink, WE; Kapel, RH; Mastrobattista, E; Roholl, PJ; Storm, G | 1 |
| Ahmad, H; Miller, EG; Patil, BS; Tang, L; Tian, Q | 1 |
| Falkson, G; Falkson, HC; van den Bergh, JA; van der Merwe, AM; van Dyk, JJ; van Eden, EB | 1 |
| Madiyalakan, R; Matta, KL; Piskorz, CF; Piver, MS | 1 |
23 other study(ies) available for glucose, (beta-d)-isomer and Cancer of Ovary
| Article | Year |
|---|---|
Effect of cisplatin on the oxidative metabolism of polymorphonuclear leukocytes in cancer patients.
Topics: Cisplatin; Cytochrome c Group; Female; Humans; Neutrophils; Ovarian Neoplasms; Oxygen Consumption; Superoxide Dismutase; Superoxides; Uterine Cervical Neoplasms; Zymosan | 1984 |
Enhancement of normal polymorphonuclear cells respiratory burst in ascitic fluid by fibronectin. Comparison between cirrhotic and malignant ascitic fluids.
Topics: Adult; Aged; Aged, 80 and over; Ascitic Fluid; Bacterial Infections; Disease Susceptibility; Dose-Response Relationship, Drug; Female; Fibronectins; Humans; Liver Cirrhosis; Luminescent Measurements; Middle Aged; Neutrophils; Ovarian Neoplasms; Peritonitis; Respiratory Burst; Risk Factors; Stomach Neoplasms; Tetradecanoylphorbol Acetate; Zymosan | 1992 |
The Effect of Calycosin-7-O-β-D-Glucoside and its Synergistic Augmentation of Cisplatin-induced Apoptosis in SK-OV-3 Cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Ovarian Epithelial; Caspase 3; Cell Line, Tumor; Cisplatin; Female; Glucosides; Humans; Isoflavones; Ovarian Neoplasms; Tumor Suppressor Protein p53 | 2022 |
Ceramide-Rubusoside Nanomicelles, a Potential Therapeutic Approach to Target Cancers Carrying p53 Missense Mutations.
Topics: Animals; Cell Line, Tumor; Ceramides; Diterpenes, Kaurane; Female; Glucosides; Humans; Mice; Mice, Nude; Mice, Transgenic; Micelles; Mutation, Missense; Nanoparticles; Ovarian Neoplasms; Random Allocation; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2020 |
Physcion-8-O-β-d-glucoside interferes with the nuclear factor-κB pathway and downregulates P-glycoprotein expression to reduce paclitaxel resistance in ovarian cancer cells.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Emodin; Female; Glucosides; Humans; Ovarian Neoplasms; Paclitaxel; Transcription Factor RelA; Xenograft Model Antitumor Assays | 2021 |
Geraniin suppresses ovarian cancer growth through inhibition of NF-κB activation and downregulation of Mcl-1 expression.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Female; Glucosides; Humans; Hydrolyzable Tannins; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Myeloid Cell Leukemia Sequence 1 Protein; Ovarian Neoplasms; Transcription Factor RelA; Xenograft Model Antitumor Assays | 2017 |
Aloesin Suppresses Cell Growth and Metastasis in Ovarian Cancer SKOV3 Cells through the Inhibition of the MAPK Signaling Pathway.
Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chromones; Female; Glucosides; Humans; MAP Kinase Signaling System; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Ovarian Neoplasms; Phosphorylation; Time Factors; Xenograft Model Antitumor Assays | 2017 |
Corilagin sensitizes epithelial ovarian cancer to chemotherapy by inhibiting Snail‑glycolysis pathways.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carboplatin; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Glucosides; Glycolysis; Herbal Medicine; Humans; Hyaluronan Receptors; Hydrolyzable Tannins; Neoplasm Proteins; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Proteomics; Signal Transduction; STAT3 Transcription Factor | 2017 |
Salidroside, a Chemopreventive Glycoside, Diminishes Cytotoxic Effect of Cisplatin in Vitro.
Topics: Anticarcinogenic Agents; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Comet Assay; DNA Damage; Drug Antagonism; Drug Synergism; Female; Glucosides; Hep G2 Cells; Hepatocytes; Humans; Ovarian Neoplasms; Phenols; Protective Agents; Reproducibility of Results; Signal Transduction | 2018 |
Corilagin from longan seed: Identification, quantification, and synergistic cytotoxicity on SKOv3ip and hey cells with ginsenoside Rh2 and 5-fluorouracil.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Therapy, Combination; Female; Fluorouracil; Free Radical Scavengers; Ginsenosides; Glucosides; Humans; Hydrolyzable Tannins; Nitrites; Nitrosamines; Ovarian Neoplasms; Sapindaceae; Seeds | 2018 |
Physcion 8-O-β-glucopyranoside exhibits anti-growth and anti-metastatic activities in ovarian cancer by downregulating miR-25.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Emodin; Female; Gene Expression Regulation, Neoplastic; Glucosides; Humans; MicroRNAs; Molecular Structure; Ovarian Neoplasms | 2019 |
Involvement of NORAD/miR-608/STAT3 axis in carcinostasis effects of physcion 8-O-β-glucopyranoside on ovarian cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Emodin; Female; Glucosides; Humans; MicroRNAs; Middle Aged; Neoplasm Invasiveness; Ovarian Neoplasms; RNA, Long Noncoding; STAT3 Transcription Factor; Up-Regulation | 2019 |
A potential anti-tumor herbal medicine, Corilagin, inhibits ovarian cancer cell growth through blocking the TGF-β signaling pathways.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin B1; Down-Regulation; Epithelial Cells; Female; Glucosides; Humans; Hydrolyzable Tannins; Inhibitory Concentration 50; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Ovary; Paclitaxel; Phyllanthus; Phytotherapy; Plant Extracts; Smad Proteins; Transforming Growth Factor beta; Transplantation, Heterologous; Xenograft Model Antitumor Assays | 2013 |
Effects of Flaxseed Lignan Secoisolariciresinol Diglucosideon Preneoplastic Biomarkers of Cancer Progression in a Model of Simultaneous Breast and Ovarian Cancer Development.
Topics: Animals; Biomarkers, Tumor; Breast Neoplasms; Butylene Glycols; Cell Adhesion; Disease Models, Animal; Disease Progression; Drug Evaluation, Preclinical; Estrogen Receptor Modulators; Female; Flax; Glucosides; Ki-67 Antigen; Ovarian Neoplasms; Phytoestrogens; Precancerous Conditions; Rats; Rats, Inbred ACI; Seeds | 2015 |
[Effects of emodin-8-O-β-D-glucoside on cell apoptosis and expression of Bcl-2/Bax in cervical cancer SKOV3 cells].
Topics: Anthraquinones; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Emodin; Female; Glucosides; Humans; Ovarian Neoplasms; Proto-Oncogene Proteins c-bcl-2; Uterine Cervical Neoplasms | 2015 |
A new acetophenone glycoside from the flower buds of Syzygium aromaticum (cloves).
Topics: Acetophenones; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Female; Flowers; Glucosides; Humans; Molecular Structure; Ovarian Neoplasms; Syzygium | 2016 |
[Study on anti-tumor effect of cyanidin-3-glucoside on ovarian cancer].
Topics: Animals; Anthocyanins; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Ki-67 Antigen; Mice; Mice, Inbred BALB C; Mucin-4; Ovarian Neoplasms; Xenograft Model Antitumor Assays | 2012 |
Cellular determinants of resistance to indolocarbazole analogue 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13(beta-D-glucopyranosyl)- 5H-indolo[2,3-alpha]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506), a novel potent topoisomerase I inhibitor, in multid
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Blotting, Northern; Camptothecin; Carbazoles; Cell Count; Chromatography, High Pressure Liquid; DNA Topoisomerases, Type I; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Fibrosarcoma; Glucosides; Humans; Multidrug Resistance-Associated Proteins; Ovarian Neoplasms; RNA, Messenger; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1997 |
Indolocarbazole poisons of human topoisomerase I: regioisomeric analogues of ED-110.
Topics: Antineoplastic Agents; Camptothecin; Carbazoles; Female; Glucosides; HT29 Cells; Humans; Inhibitory Concentration 50; Male; Ovarian Neoplasms; Prostatic Neoplasms; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1999 |
Lipid-coated polyplexes for targeted gene delivery to ovarian carcinoma cells.
Topics: Animals; DNA; Dose-Response Relationship, Drug; Female; Gene Transfer Techniques; Glucosides; Humans; Hyaluronic Acid; Lipid Metabolism; Methacrylates; Mice; Mice, Nude; Micelles; Microscopy, Electron; Ovarian Neoplasms; Plasmids; Transfection; Tumor Cells, Cultured | 2001 |
Differential inhibition of human cancer cell proliferation by citrus limonoids.
Topics: Apoptosis; Benzopyrans; Benzoxepins; Breast Neoplasms; Cell Division; Citrus; DNA, Neoplasm; Female; Flow Cytometry; Glucosides; Humans; Leukemia; Limonins; Liver Neoplasms; Neoplasms; Ovarian Neoplasms; Plant Extracts; Stomach Neoplasms; Triterpenes; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2001 |
A clinical trial of the oral form of 4'-demethyl-epipodophyllotoxin-beta-D ethylidene glucoside (NSC 141540) VP 16-213.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Administration, Oral; Breast Neoplasms; Carcinoma; Colonic Neoplasms; Female; Glucosides; Humans; Leukemia, Myeloid; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Mesothelioma; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Podophyllotoxin; Remission, Spontaneous; Urinary Bladder Neoplasms | 1975 |
Serum beta-(1----4)-galactosyltransferase activity with synthetic low molecular weight acceptor in human ovarian cancer.
Topics: beta-N-Acetylglucosaminylglycopeptide beta-1,4-Galactosyltransferase; Chromatography; Female; Galactosyltransferases; Glucosides; Glycosides; Humans; Mannosides; Molecular Weight; Ovarian Neoplasms | 1987 |